|Systematic (IUPAC) name|
|AHFS/Drugs.com||Micromedex Detailed Consumer Information|
|Bioavailability||37 to 90%|
|Biological half-life||30 minutes to 1 hour|
|Excretion||Renal and biliary|
|ATC code||J01CF02 (WHO) QJ51CF02 (WHO) QS01AA90 (WHO)|
|Molar mass||435.88 g/mol|
Cloxacillin is used against staphylococci that produce beta-lactamase, due to its large R chain, which does not allow the beta-lactamases to bind. This drug has a weaker antibacterial activity than benzylpenicillin, and is devoid of serious toxicity except for allergic reactions.
Cloxacillin was discovered and developed by Beecham. It is sold under a number of trade names, including Cloxapen, Cloxacap, Tegopen and Orbenin. It is on the World Health Organization's List of Essential Medicines, the most important medication needed in a basic health system.
- David Greenwood (2008). Antimicrobial drugs: chronicle of a twentieth century medical triumph. Oxford University Press US. pp. 124–. ISBN 978-0-19-953484-5. Retrieved 18 November 2010.
- "WHO Model List of EssentialMedicines" (PDF). World Health Organization. October 2013. Retrieved 22 April 2014.
|This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.|